Three trials pooled data on left-sided, RAS/BRAF wild-type metastatic CRC to compare toxicity profiles of different maintenance approaches. (Journal of the National Cancer Institute)
RAS/BRAF wild-type patients: Maintenance strategies compared
The CRC Digest